ArticleCell2021

A reply to "TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes".

Rizwan Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.